187 related articles for article (PubMed ID: 18777001)
41. Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Collis R; Watkinson O; O'Mahony C; Guttmann OP; Pantazis A; Tome-Esteban M; Tsang V; Chandrasekaran V; McGregor CGA; Elliott PM
Eur J Heart Fail; 2018 Feb; 20(2):398-405. PubMed ID: 29148156
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
[TBL] [Abstract][Full Text] [Related]
43. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
44. Percutaneous transluminal septal myocardial ablation: past, present, and future.
Maekawa Y; Takamisawa I; Takano H; Takayama M
J Cardiol; 2022 Sep; 80(3):211-217. PubMed ID: 34924238
[TBL] [Abstract][Full Text] [Related]
45. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
[TBL] [Abstract][Full Text] [Related]
46. Percutaneous transluminal septal myocardial ablation.
Rubin DN; Tuzcu EM; Lever HM
Curr Cardiol Rep; 2000 Mar; 2(2):160-5. PubMed ID: 10980888
[TBL] [Abstract][Full Text] [Related]
47. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
48. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.
Sitges M; Shiota T; Lever HM; Qin JX; Bauer F; Drinko JK; Agler DA; Martin MG; Greenberg NL; Smedira NG; Lytle BW; Tuzcu EM; Garcia MJ; Thomas JD
Am J Cardiol; 2003 Apr; 91(7):817-21. PubMed ID: 12667567
[TBL] [Abstract][Full Text] [Related]
49. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
[TBL] [Abstract][Full Text] [Related]
50. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
[TBL] [Abstract][Full Text] [Related]
51. Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS; Rastegar H; Dolan N; Carpino P; Koethe B; Maron BJ; Rowin EJ
Am J Cardiol; 2022 Jan; 163():91-97. PubMed ID: 34785034
[TBL] [Abstract][Full Text] [Related]
52. New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard?
Hess OM; Sigwart U
J Am Coll Cardiol; 2004 Nov; 44(10):2054-5. PubMed ID: 15542291
[TBL] [Abstract][Full Text] [Related]
53. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
54. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
[TBL] [Abstract][Full Text] [Related]
55. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
Smedira NG; Lytle BW; Lever HM; Rajeswaran J; Krishnaswamy G; Kaple RK; Dolney DO; Blackstone EH
Ann Thorac Surg; 2008 Jan; 85(1):127-33. PubMed ID: 18154797
[TBL] [Abstract][Full Text] [Related]
56. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
[TBL] [Abstract][Full Text] [Related]
57. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. A new therapeutic option].
Mogensen J; Egeblad H; Hansen PS; Jensen HK; Thuesen L
Ugeskr Laeger; 2000 Mar; 162(10):1371-5. PubMed ID: 10745674
[TBL] [Abstract][Full Text] [Related]
58. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Jensen MK; Havndrup O; Pecini R; Dalsgaard M; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
Eur J Echocardiogr; 2010 Oct; 11(9):763-9. PubMed ID: 20472917
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
60. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
